Post by
biorun on Jun 20, 2022 7:40am
Senior VP from Bayer as Board Member
This is the kind of specific move institutional investors will wish to see.
As he says, Sirona is "a Diamond in the Rough".
Well done Howard.
Comment by
Tickel1st on Jun 20, 2022 7:58am
This post has been removed in accordance with Community Policy
Comment by
Transperance on Jun 20, 2022 9:18am
Yes, additional board members with supplementing competences and experiences should absolutely be recruited to the board. Some of the present board members could also be replaced. There is an urgent need to get an adequate governance top-down in the organisation regardless of listing and potential up-listing.
Comment by
biorun on Jun 20, 2022 11:23am
Looks like we only have part of the story here. The give back today may be temporary as some profits taken. The stock is nowhere near done with its rise.
Comment by
doonery on Jun 20, 2022 12:18pm
i agree biorun,,,as usual i think you are correct,,in fact I bought some more at .31,,,I think 40+,by thurs/fri.GLTA,,,
Comment by
navajojoe on Oct 25, 2022 3:44pm
This post has been removed in accordance with Community Policy
Comment by
doonery on Jun 20, 2022 12:19pm
i agree biorun,,,as usual i think you are correct,,in fact I@ bought some more at .31,,,I think 40+,by thurs/fri.GLTA,,,